Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy

Lauren Imbornoni, Elinora T. Price, Jennifer Andrews, F. John Meaney, Emma Ciafaloni, Christopher M Cunniff

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Manifestations of Duchenne and Becker muscular dystrophy (DBMD) are present in up to 40% of heterozygous females, but there are few reports of females who exhibit skeletal muscle symptoms in childhood. From the Muscular Dystrophy Surveillance Tracking and Research Network, a multi-site population-based surveillance network for dystrophinopathy, nine symptomatic female heterozygotes with onset of symptoms prior to age 9 years were identified. The median age at diagnosis was 8.3 years, and the median interval from first symptoms to diagnosis was 1.35 years. Of the nine female heterozygotes, four had a positive family history, seven had intellectual disability and five had at least one mental health disorder. Mental health concerns included attention deficit hyperactivity disorder (ADHD), autism spectrum features, bipolar disorder, and depression. The frequency of intellectual and mental health problems in this group is higher than previously reported for affected males and for symptomatic females. These findings may have implications for diagnosis of early manifesting heterozygotes and for their health supervision.

Original languageEnglish (US)
Pages (from-to)2769-2774
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume164
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

Duchenne Muscular Dystrophy
Heterozygote
Mental Health
Bipolar Disorder
Population Surveillance
Muscular Dystrophies
Attention Deficit Disorder with Hyperactivity
Autistic Disorder
Mental Disorders
Intellectual Disability
Skeletal Muscle
Health
Research

Keywords

  • Duchenne muscular dystrophy
  • Dystrophinopathy
  • Manifesting heterozygote

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy. / Imbornoni, Lauren; Price, Elinora T.; Andrews, Jennifer; Meaney, F. John; Ciafaloni, Emma; Cunniff, Christopher M.

In: American Journal of Medical Genetics, Part A, Vol. 164, No. 11, 01.11.2014, p. 2769-2774.

Research output: Contribution to journalArticle

Imbornoni, Lauren ; Price, Elinora T. ; Andrews, Jennifer ; Meaney, F. John ; Ciafaloni, Emma ; Cunniff, Christopher M. / Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy. In: American Journal of Medical Genetics, Part A. 2014 ; Vol. 164, No. 11. pp. 2769-2774.
@article{a1ea9ad230f44b28bda464f2c25d1ffd,
title = "Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy",
abstract = "Manifestations of Duchenne and Becker muscular dystrophy (DBMD) are present in up to 40{\%} of heterozygous females, but there are few reports of females who exhibit skeletal muscle symptoms in childhood. From the Muscular Dystrophy Surveillance Tracking and Research Network, a multi-site population-based surveillance network for dystrophinopathy, nine symptomatic female heterozygotes with onset of symptoms prior to age 9 years were identified. The median age at diagnosis was 8.3 years, and the median interval from first symptoms to diagnosis was 1.35 years. Of the nine female heterozygotes, four had a positive family history, seven had intellectual disability and five had at least one mental health disorder. Mental health concerns included attention deficit hyperactivity disorder (ADHD), autism spectrum features, bipolar disorder, and depression. The frequency of intellectual and mental health problems in this group is higher than previously reported for affected males and for symptomatic females. These findings may have implications for diagnosis of early manifesting heterozygotes and for their health supervision.",
keywords = "Duchenne muscular dystrophy, Dystrophinopathy, Manifesting heterozygote",
author = "Lauren Imbornoni and Price, {Elinora T.} and Jennifer Andrews and Meaney, {F. John} and Emma Ciafaloni and Cunniff, {Christopher M}",
year = "2014",
month = "11",
day = "1",
doi = "10.1002/ajmg.a.36728",
language = "English (US)",
volume = "164",
pages = "2769--2774",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy

AU - Imbornoni, Lauren

AU - Price, Elinora T.

AU - Andrews, Jennifer

AU - Meaney, F. John

AU - Ciafaloni, Emma

AU - Cunniff, Christopher M

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Manifestations of Duchenne and Becker muscular dystrophy (DBMD) are present in up to 40% of heterozygous females, but there are few reports of females who exhibit skeletal muscle symptoms in childhood. From the Muscular Dystrophy Surveillance Tracking and Research Network, a multi-site population-based surveillance network for dystrophinopathy, nine symptomatic female heterozygotes with onset of symptoms prior to age 9 years were identified. The median age at diagnosis was 8.3 years, and the median interval from first symptoms to diagnosis was 1.35 years. Of the nine female heterozygotes, four had a positive family history, seven had intellectual disability and five had at least one mental health disorder. Mental health concerns included attention deficit hyperactivity disorder (ADHD), autism spectrum features, bipolar disorder, and depression. The frequency of intellectual and mental health problems in this group is higher than previously reported for affected males and for symptomatic females. These findings may have implications for diagnosis of early manifesting heterozygotes and for their health supervision.

AB - Manifestations of Duchenne and Becker muscular dystrophy (DBMD) are present in up to 40% of heterozygous females, but there are few reports of females who exhibit skeletal muscle symptoms in childhood. From the Muscular Dystrophy Surveillance Tracking and Research Network, a multi-site population-based surveillance network for dystrophinopathy, nine symptomatic female heterozygotes with onset of symptoms prior to age 9 years were identified. The median age at diagnosis was 8.3 years, and the median interval from first symptoms to diagnosis was 1.35 years. Of the nine female heterozygotes, four had a positive family history, seven had intellectual disability and five had at least one mental health disorder. Mental health concerns included attention deficit hyperactivity disorder (ADHD), autism spectrum features, bipolar disorder, and depression. The frequency of intellectual and mental health problems in this group is higher than previously reported for affected males and for symptomatic females. These findings may have implications for diagnosis of early manifesting heterozygotes and for their health supervision.

KW - Duchenne muscular dystrophy

KW - Dystrophinopathy

KW - Manifesting heterozygote

UR - http://www.scopus.com/inward/record.url?scp=84911403020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911403020&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.36728

DO - 10.1002/ajmg.a.36728

M3 - Article

C2 - 25125379

AN - SCOPUS:84911403020

VL - 164

SP - 2769

EP - 2774

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 11

ER -